Association between malignancy risk and Janus kinase inhibitors versus tumour necrosis factor inhibitors in Korean patients with rheumatoid arthritis: a nationwide population-based study

OBJECTIVE: To determine the risk of malignancy in Korean patients with rheumatoid arthritis (RA) receiving Janus kinase inhibitors (JAKis) compared with tumour necrosis factor inhibitors (TNFis). METHODS: A retrospective cohort of patients with RA initiating their first JAKi or TNFi was established...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yeo-Jin, Cho, Soo-Kyung, You, Seung-Hun, Kim, Jeong-Yeon, Kim, Hyoungyoung, Jung, Sun-Young, Sung, Yoon-Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791465/
https://www.ncbi.nlm.nih.gov/pubmed/36549855
http://dx.doi.org/10.1136/rmdopen-2022-002614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791465/
https://www.ncbi.nlm.nih.gov/pubmed/36549855
http://dx.doi.org/10.1136/rmdopen-2022-002614

Ejemplares similares